Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Nutex Health (NUTX) Income towards Parent Company: 2009-2024

Historic Income towards Parent Company for Nutex Health (NUTX) over the last 13 years, with FY2024 value amounting to $94.8 million.

  • Nutex Health's Income towards Parent Company rose 145099.79% to $96.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $263.7 million, marking a year-over-year increase of 91373.51%. This contributed to the annual value of $94.8 million for FY2024, which is 31832.65% up from last year.
  • Nutex Health's Income towards Parent Company amounted to $94.8 million in FY2024, which was up 31832.65% from -$43.4 million recorded in FY2023.
  • Over the past 5 years, Nutex Health's Income towards Parent Company peaked at $94.8 million during FY2024, and registered a low of -$432.7 million during FY2022.
  • For the 4-year period, Nutex Health's Income towards Parent Company averaged around -$95.4 million, with its median value being -$21.8 million (2020).
  • Its Income towards Parent Company has fluctuated over the past 5 years, first surged by 8996.54% in 2023, then surged by 31832.65% in 2024.
  • Nutex Health's Income towards Parent Company (Annual) stood at -$118992.0 in 2020, then plummeted by 363571.19% to -$432.7 million in 2022, then surged by 89.97% to -$43.4 million in 2023, then skyrocketed by 318.33% to $94.8 million in 2024.
  • Its Income towards Parent Company stands at $94.8 million for FY2024, versus -$43.4 million for FY2023 and -$432.7 million for FY2022.